Armor Health Partners with Antidote-AI for Correctional Healthcare AI Tools
Armor Health has announced a new partnership with Antidote-AI to enhance its healthcare services in correctional facilities. In a press release, Armor Health revealed that Antidote-AI's clinical tools will be integrated into Armor's Insights Analytics platform. This integration aims to provide real-time patient data and objective scoring, enabling healthcare providers to make informed treatment decisions.
Antidote-AI's technology, which has been tested across a diverse patient population, will help streamline patient care processes and improve treatment efficiency. Armor Health has already begun implementing these AI solutions across its facilities, working with current client partners to enhance healthcare outcomes for incarcerated individuals.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
AstraZeneca and Oracle Partner on AI for Clinical Trials
Andor Health Receives 2026 Frost & Sullivan Recognition for AI Care Orchestration
Optum and Alameda Alliance Partner on AI Claims Automation
MEDITECH and Lifemed AI Partner on Claims Automation
Specialty1 Partners Invests in AI for Dental Practice Operations
Daily AI Brief: the AI news that matters, in your inbox.